|
Post by uvula on Aug 25, 2023 14:35:07 GMT -5
Mannkind just posted this on facebook:
This weekend we look to Saarbrücken, Germany, where the International Society for Aerosols in Medicine (ISAM) 2023 Congress gets underway. MannKind is proud to sponsor ISAM and see its very own Chief Scientific Officer Thomas Hofmann, PhD, speak at a workshop discussing inhaled antibiotics and development of clofazimine (MNKD-101) and potential treatment of nontuberculous mycobacterial (NTM) lung disease. An abstract regarding the development of Nintedanib Technosphere® powder (MNKD-201) for targeted lung delivery in the treatment of idiopathic pulmonary fibrosis will also be presented at the conference. @aerosolmedicine #MannKind #MNKD #NTMlungDisease #IPF
|
|